These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1669833)

  • 1. Labelling of tumour cells with a biotinylated inhibitor of a cell surface protease.
    Steven FS; Griffin MM; Williams LA; Clarke NW; Maier H
    J Enzyme Inhib; 1991; 4(4):337-46. PubMed ID: 1669833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive inhibition of a tumour cell surface protease. A rapid technique for in vitro testing of selective targeting systems.
    Steven FS; Griffin MM; Barnett FB; Epenetos AA
    J Enzyme Inhib; 1990; 4(1):63-73. PubMed ID: 2094772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporary competitive inhibition of a tumour cell surface protease as a protective mechanism in the preparation of the membrane bound native enzyme in the presence of excess cytoplasmic inhibitors.
    Steven FS; Griffin MM; Maier H
    J Enzyme Inhib; 1991; 5(1):77-85. PubMed ID: 1669439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The targeting of agmatine-liganded mitomycin C to an enzyme on the surface of tumour cells.
    Steven FS; Griffin MM; Talbot IC
    Anticancer Res; 1990; 10(3):583-9. PubMed ID: 2114817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association and dissociation of a protease and its inhibitor on the surface of lung squamous cell carcinoma cells.
    Steven FS; Anees M; Myers J; Hasleton P
    Anticancer Res; 1993; 13(4):1063-8. PubMed ID: 8352526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of a cell surface protease after cisplatin chemotherapy.
    Steven FS; Zoeller J; Maier H; Born IA
    J Enzyme Inhib; 1991; 5(2):151-64. PubMed ID: 1669443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interactions of protein inhibitors with tumour proteases studied in solution and immobilised on cell surfaces in frozen sections.
    Steven FS; Anees M; Talbot IC; Blakey DC; Hasleton PS
    Anticancer Res; 1993; 13(6A):2003-10. PubMed ID: 8297107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorescent study of ligands for guanidinobenzoatase, a protease associated with tumour cells.
    Steven F; Griffin MM; Williams LA; Feichter G
    Anticancer Res; 1988; 8(6):1179-83. PubMed ID: 3218954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence for the cell surface location of a protease-inhibitor complex on intact leukaemia cells.
    Steven FS; Griffin MM
    J Enzyme Inhib; 1990; 3(4):311-6. PubMed ID: 2319334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective role of a natural inhibitor in the fluorescent location of cells possessing a latent form of cell surface protease.
    Steven FS; Williams LA
    J Enzyme Inhib; 1990; 3(4):317-22. PubMed ID: 1690794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent inhibitors of a cell surface protease used to locate leukaemia cells in kidney sections.
    Steven FS; Griffin MM; Wong TL; Jackson H; Barnett F
    J Enzyme Inhib; 1987; 1(3):203-13. PubMed ID: 3334245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location of tumour cells in colon tissue by Texas red labelled pentosan polysulphate, an inhibitor of a cell surface protease.
    Anees M
    J Enzyme Inhib; 1996; 10(3):203-14. PubMed ID: 8835946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting adriamycin to tumour cells by means of an affinity ligand; a model system for drug delivery.
    Steven FS; Griffin MM; Williams LA; Ali H; Maier H
    Anticancer Res; 1989; 9(1):247-53. PubMed ID: 2705751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity preparation of a protein inhibitor recognising a cell surface protease.
    Steven FS; Griffin MM; Bell J; Talbot IC
    J Enzyme Inhib; 1993; 7(1):65-76. PubMed ID: 7510796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for cells possessing t-PA like activity in smears obtained from patients with oral squamous cell carcinoma.
    Steven FS; Griffin MM; Zoeller J; Maier H
    Anticancer Res; 1990; 10(4):995-9. PubMed ID: 2116754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the conformational changes in the structure of a cell surface protease, followed by its ability to be recognised by competitive and non-competitive inhibitors.
    Steven FS; Griffin MM; Anees M; Benbow EW
    J Enzyme Inhib; 1992; 6(3):251-8. PubMed ID: 1284962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fibrin fibrils in the dissociation of a cell surface protease-inhibitor complex and evidence for the recapture of the inhibitor protein.
    Steven FS; Blakey DC
    J Enzyme Inhib; 1992; 5(4):299-315. PubMed ID: 1285251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel agmatine and agmatine-like peptidomimetic inhibitors of the West Nile virus NS2B/NS3 serine protease.
    Lim HA; Joy J; Hill J; San Brian Chia C
    Eur J Med Chem; 2011 Jul; 46(7):3130-4. PubMed ID: 21565434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of a tumour protease with 3,4-dichloroisocoumarin, pentamidine-isethionate and guanidino derivatives.
    Anees M; Steven FS
    J Enzyme Inhib; 1994; 8(3):213-21. PubMed ID: 7539490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of a novel biotinylated affinity label for the detection of a cathepsin B-like precursor produced by breast-tumour cells in culture.
    Cullen BM; Halliday IM; Kay G; Nelson J; Walker B
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):461-5. PubMed ID: 1575692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.